Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scanfil Q4’24: No room for surprises

SCANFL2025-02-26 09:54
Antti Viljakainen, Sara Antonacci
Discuss

Scanfil’s performance is showing signs of a turnaround. In Q4, Scanfil's revenue decreased by 4% to 212 MEUR from a good comparison level, which was slightly above our forecast. Fundamentally the demand outlook should be improving. Head of research Antti Viljakainen summarizes.

NB! Due to a mic failure, the audio is not up to normal standards. We apologize for the poor audio quality.

00:00 Intro
00:14 O4 summarized
01:42 SRX acquisition
03:23 Inventory sold in Q4
04:47 Profitability
05:47 Outlook for the near future
08:04 Valuation & recommendation

Read the latest research: Expected return determined by earnings growth

Stay up to date
Analyst Interviews

Upcoming webcasts

Recent videos

CapMan Q2’26: Framsteg i kapitalanskaffning
2026-08-24 11:22 CapMan
Implantica, Audiocast, Q2'26
2026-08-21 15:00 Implantica
SP Group – Presentation of the quarterly report for Q2 2026
2026-08-21 15:00 SP Group
United Bankers H1’26: Fokus på internationell försäljning
2026-08-21 14:02 United Bankers
Egetis Therapeutics, Audiocast, Q2'26
2026-08-21 14:00 Egetis Therapeutics
View all videos